MiMedx Group Inc. (NASDAQ:MDXG) shares dropped 2.3% during mid-day trading on Monday . The company traded as low as $6.94 and last traded at $7.07, with a volume of 667,715 shares changing hands. The stock had previously closed at $7.24.

MDXG has been the topic of a number of analyst reports. Brean Capital reiterated a “buy” rating on shares of MiMedx Group in a report on Thursday, May 12th. Zacks Investment Research upgraded MiMedx Group from a “sell” rating to a “hold” rating in a report on Wednesday, June 29th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $10.89.

The firm has a market cap of $793.95 million and a PE ratio of 34.194. The firm has a 50-day moving average of $7.55 and a 200 day moving average of $7.88.

MiMedx Group (NASDAQ:MDXG) last issued its quarterly earnings data on Tuesday, July 26th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.02. The company earned $57 million during the quarter, compared to the consensus estimate of $56.49 million. During the same period last year, the firm earned $0.05 EPS. The business’s revenue for the quarter was up 25.5% compared to the same quarter last year. Analysts predict that MiMedx Group Inc. will post $0.23 earnings per share for the current year.

In other MiMedx Group news, insider William Charles Taylor sold 29,112 shares of the company’s stock in a transaction on Monday, August 1st. The stock was sold at an average price of $7.55, for a total transaction of $219,795.60. Following the transaction, the insider now directly owns 612,316 shares in the company, valued at $4,622,985.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

A hedge fund recently raised its stake in MiMedx Group stock. Wells Fargo & Company MN boosted its position in MiMedx Group Inc. (NASDAQ:MDXG) by 19.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,041,546 shares of the company’s stock after buying an additional 169,102 shares during the period. Wells Fargo & Company MN owned approximately 0.96% of MiMedx Group worth $9,759,000 at the end of the most recent reporting period.

MiMedx Group, Inc (MiMedx) is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. The Company operates in the Regenerative Biomaterials business segment, which includes the development, processing and marketing of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues in the wound care, surgical, sports medicine, ophthalmic and dental market categories.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.